Groupe Berkem Announces Its 2024 Financial Calendar

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News:

Groupe Berkem (the “Group”) (Paris:ALKEM), a leading player in bio-based chemicals (ISIN code: FR00140069V2 – Ticker: ALKEM), announces today its 2024 financial calendar.

Event	Date *
2023 Full-Year Revenue	January 31, 2024
2023 Full-Year Results	April 29, 2024
2024 First-Quarter Revenue	April 29, 2024
Annual General Meeting	June 25, 2024
2024 First-Half Revenue	July 25, 2024
2024 First-Half Results	September 26, 2024
2024 Third-Quarter Revenue	October 24, 2024

* this information is subject to modification.

ABOUT GROUPE BERKEM

Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday life (Construction & Materials, Health, Beauty & Nutrition, Hygiene & Protection, and Industry). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters—unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €51.8 million in 2022. The Group has almost 200 employees working at its head office (Blanquefort, Gironde) and 4 production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and Tonneins (Lot-et-Garonne).

Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN code: FR00140069V2 - ALKEM).

www.groupeberkem.com